Atlas Trials

Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

Clinical trial NCT02521246 · WITHDRAWN

Trial details

NCT number
NCT02521246
Sponsor
EMS
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Essential Arterial Hypertension
Start date
2016-11-01
Primary completion
2017-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.